“Becoming an Alzheimer’s patient is almost always a choice. This conference explains why.” Dr David Perlmutter, neurologist
The evidence is clear. It’s time for prevention to lead clinical practice.
Fewer than 1% of Alzheimer’s cases are caused by genes. Which means that, for 99 per cent of people, the majority of risk is modifiable.
This conference brings together world-class scientists and clinicians to explore the metabolic, nutritional, and lifestyle drivers of brain ageing. Over one focused day, leading researchers will present the latest evidence, emerging biomarkers, and practical pathways that make prevention a reality, with measurable interventions practitioners can use right now.
This is for any clinician wishing to be up to date and ready to move beyond outdated narratives and step into a systems-based approach grounded in biology and evidence-based science.
Join practitioners from the UK, North America and beyond.
Drawing directly from the research presented by our speakers, this conference will show you:
The emerging picture of amyloid, why the story has changed, and what the evidence now tells us about underlying pathology. It is a fireman, not the fire.
An update on predictive biomarkers, from amyloid, p-tau and homocysteine
The central role of homocysteine as a causal and measurable driver of decline
The critical interaction between omega-3 and B vitamins that creates neuronal integrity
Why phospholipids form the backbone of healthy brain architecture
The impact of menopause, hormones and disrupted sleep on long-term cognitive resilience
The need for brain stimulation to build and maintain the neural network
The influence of sugar, ultra-processed food, insulin resistance and microvascular stress on the ageing brain
How ketones energise the brain when glucose transport is compromised
The growing evidence around periodontal, gut and microbial infections as hidden accelerants of inflammation
Why reducing oxidative stress, promoting glutathione, and plant-derived polyphenols are key for cellular protection
How nutritional biomarkers and real-world citizen science data from the COGNITION Biobank are helping to define personalised prevention
Prevention is no longer theoretical. It is doable. It is the new clinical frontier.
Reserve your seat and join the global movement reshaping Alzheimer’s prevention.
• Nutrition • Functional and integrative medicine • Primary care and general practice • Naturopathic and lifestyle medicine
• Ageing, metabolic health and neurology • Coaching, nursing and allied health professions • Research and academic settings
If you support patients in midlife or older, this knowledge is essential. It will also provide you with the blueprint for dementia-proofing your own diet and lifestyle.
WHAT THIS MEANS FOR YOUR PRACTICE
This conference will equip you to:
Spot the patterns and be equipped with the tools to reverse cognitive risk.
Integrate nutritional biomarkers into assessment with clarity and confidence.
Prioritise interventions based on biological relevance, not trends.
Make sense of conflicting data around amyloid, p-tau and diagnostics.
Translate complex systems-based science into clear patient pathways.
Strengthen neurological resilience and mental health based on the most up-to-date evidence.
Bring personalised, prevention-led strategies into everyday appointments.
Support patients with practical, measurable steps that improve outcomes.
